Asthma may be more harmful than was previously thought, according to UCLA researchers who found that genetic damage is present in circulating, or peripheral, blood. Doctors previously thought that the genetic damage it caused was limited to the lungs.
In the study, researchers looked for the overexpression of a cytokine called interleukin 13 (IL-13), which is known to mediate inflammation, a critical problem for people with asthma.
Asthma, a chronic disease that inflames and narrows the airways of the lungs, affects more than 150 million individuals worldwide. It causes recurring periods of wheezing, chest tightness, shortness of breath and coughing, and the symptoms can worsen at any time, making breathing difficult. There is no cure.
Asthma affects people of all ages, but it most often starts during childhood. More than 25 million Americans are known to have the disease, including about 7 million children. There are two types of asthma, allergic and non-allergic asthma, which account for 70 and 30 percent of cases respectively. Non-allergic asthmatics experience more severe and more frequent symptoms.
The study, which was conducted in an animal model that mimicked human asthma, was the first to assess the role of IL-13 in genetic damage to cells, or genotoxicity. Asthma is a very widespread disease, and the team showed for the first time an association between asthma and genotoxicity in peripheral blood. This is important because it shows a whole-body effect from asthma, not just damage in the lungs.
The group observed that IL-13 increases important elements of the inflammatory response, including reactive oxygen species molecules, ions or very small molecules that include free radicals. The research team found that ROS-derived oxidative stress induced genetic damage with four types of systemic effects in the peripheral blood, oxidative DNA damage, single and double DNA strand breaks, micronucleus formation, and protein damage.
The team summise that all four effects causes the chromosomes to become unstable, which could result in a variety of other diseases.
The researchers found four different markers of DNA damage and one marker of protein damage in blood cells in the body periphery, which was very surprising. This could indicate that other organs in asthmatics have a higher risk of developing disease.
The team will next attempt to use chemicals that help repair the DNA of damaged cells. Their goal is to determine whether doing so can make asthma less damaging by reducing genetic instability in the peripheral blood supply.
Michelle Petersen is the founder of Healthinnovations, having worked in the health and science industry for over 21 years, which includes tenure within the NHS and Oxford University. Healthinnovations is a publication that has reported on, influenced, and researched current and future innovations in health for the past decade.
Michelle has been picked up as an expert writer for Informa publisher’s Clinical Trials community, as well as being listed as a blog source by the world’s leading medical journals, including the acclaimed Nature-Springer journal series.
Healthinnovations is currently indexed by the trusted Altmetric and PlumX metrics systems, respectively, as a blog source for published research globally. Healthinnovations is also featured in the world-renowned BioPortfolio, BioPortfolio.com, the life science, pharmaceutical and healthcare portal.
Most recently the Texas A&M University covered The Top 10 Healthinnovations series on their site with distinguished Professor Stephen Maren calling the inclusion of himself and his team on the list a reflection of “the hard work and dedication of my students and trainees”.
Michelle Petersen’s copy was used in the highly successful marketing campaign for the mega-hit film ‘Jumanji: The Next Level, starring Jack Black, Karen Gilian, Kevin Hart and Dwayne ‘The Rock’ Johnson. Michelle Petersen’s copywriting was part of the film’s coverage by the Republic TV network. Republic TV is the most-watched English language TV channel in India since its inception in 2017.
An avid campaigner in the fight against child sex abuse and trafficking, Michelle is a passionate humanist striving for a better quality of life for all humans by helping to provide traction for new technologies and techniques within healthcare.